104 related articles for article (PubMed ID: 24759273)
1. Colchicine effect on P-glycoprotein expression and activity: in silico and in vitro studies.
Silva R; Carmo H; Vilas-Boas V; Barbosa DJ; Palmeira A; Sousa E; Carvalho F; Bastos Mde L; Remião F
Chem Biol Interact; 2014 Jul; 218():50-62. PubMed ID: 24759273
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein induction in Caco-2 cells by newly synthetized thioxanthones prevents paraquat cytotoxicity.
Silva R; Palmeira A; Carmo H; Barbosa DJ; Gameiro M; Gomes A; Paiva AM; Sousa E; Pinto M; Bastos Mde L; Remião F
Arch Toxicol; 2015 Oct; 89(10):1783-800. PubMed ID: 25234084
[TBL] [Abstract][Full Text] [Related]
3. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
4. Induction and activation of P-glycoprotein by dihydroxylated xanthones protect against the cytotoxicity of the P-glycoprotein substrate paraquat.
Silva R; Sousa E; Carmo H; Palmeira A; Barbosa DJ; Gameiro M; Pinto M; Bastos Mde L; Remião F
Arch Toxicol; 2014 Apr; 88(4):937-51. PubMed ID: 24464498
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of P-glycoprotein induction as an antidotal pathway to prevent cytotoxicity in Caco-2 cells.
Silva R; Carmo H; Dinis-Oliveira R; Cordeiro-da-Silva A; Lima SC; Carvalho F; Bastos Mde L; Remião F
Arch Toxicol; 2011 Apr; 85(4):315-26. PubMed ID: 20857089
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo.
Zrieki A; Farinotti R; Buyse M
Eur J Pharmacol; 2010 Jun; 636(1-3):189-97. PubMed ID: 20361960
[TBL] [Abstract][Full Text] [Related]
7. P-Glycoprotein (P-gp) expressed in a confluent monolayer of hMDR1-MDCKII cells has more than one efflux pathway with cooperative binding sites.
Acharya P; Tran TT; Polli JW; Ayrton A; Ellens H; Bentz J
Biochemistry; 2006 Dec; 45(51):15505-19. PubMed ID: 17176072
[TBL] [Abstract][Full Text] [Related]
8. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of P-gp expression and function after Mulberroside A treatment: potential role of protein kinase C and NF-kappa B.
Li Y; Huang L; Zeng X; Zhong G; Ying M; Huang M; Bi H
Chem Biol Interact; 2014 Apr; 213():44-50. PubMed ID: 24530447
[TBL] [Abstract][Full Text] [Related]
10. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells.
Belliard AM; Tardivel S; Farinotti R; Lacour B; Leroy C
J Pharm Pharmacol; 2002 Aug; 54(8):1103-9. PubMed ID: 12195825
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells.
Ikemura K; Yamamoto M; Miyazaki S; Mizutani H; Iwamoto T; Okuda M
Mol Pharmacol; 2013 Feb; 83(2):399-405. PubMed ID: 23166305
[TBL] [Abstract][Full Text] [Related]
12. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells.
Eid SY; El-Readi MZ; Eldin EE; Fatani SH; Wink M
Phytomedicine; 2013 Dec; 21(1):47-61. PubMed ID: 23999162
[TBL] [Abstract][Full Text] [Related]
13. Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.
Li W; Li X; Gao Y; Zhou Y; Ma S; Zhao Y; Li J; Liu Y; Wang X; Yin D
Mol Pharm; 2014 Jan; 11(1):71-80. PubMed ID: 24256068
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
15. Colchicine derivatives with potent anticancer activity and reduced P-glycoprotein induction liability.
Singh B; Kumar A; Joshi P; Guru SK; Kumar S; Wani ZA; Mahajan G; Hussain A; Qazi AK; Kumar A; Bharate SS; Gupta BD; Sharma PR; Hamid A; Saxena AK; Mondhe DM; Bhushan S; Bharate SB; Vishwakarma RA
Org Biomol Chem; 2015 May; 13(20):5674-89. PubMed ID: 25895604
[TBL] [Abstract][Full Text] [Related]
16. Lack of P-glycoprotein induction by rifampicin and phenobarbital in human lymphocytes.
Manceau S; Giraud C; Declèves X; Batteux F; Chouzenoux S; Tang R; Dauchy S; Scherrmann JM; Weill B; Morini JP; Perrot JY; Tréluyer JM
Int J Pharm; 2010 Aug; 395(1-2):98-103. PubMed ID: 20488228
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a robust hepatitis C virus replicon cell line over-expressing P-glycoprotein that facilitates analysis of P-gp drug transporter effects on inhibitor antiviral activity.
Hernandez D; Falk P; Yu F; Zhai G; Quan Y; Faria T; Cao K; Scola P; McPhee F
Biochem Pharmacol; 2013 Jan; 85(1):21-8. PubMed ID: 23063413
[TBL] [Abstract][Full Text] [Related]
18. The utility of in vitro data in making accurate predictions of human P-glycoprotein-mediated drug-drug interactions: a case study for AZD5672.
Elsby R; Gillen M; Butters C; Imisson G; Sharma P; Smith V; Surry DD
Drug Metab Dispos; 2011 Feb; 39(2):275-82. PubMed ID: 21075975
[TBL] [Abstract][Full Text] [Related]
19. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles.
Bebawy M; Morris MB; Roufogalis BD
Anal Biochem; 1999 Mar; 268(2):270-7. PubMed ID: 10075817
[TBL] [Abstract][Full Text] [Related]
20. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells.
Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S
Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
